Remove 2019 Remove Clinical Trials Remove Sleep
article thumbnail

FDA Approves Ketamine Nasal Spray as First and Only Standalone Therapy for Treatment-Resistant Depression

Veriheal

In 2019, the FDA approved Spravato to treat treatment-resistant depression (TRD), with optional uses alone or alongside oral antidepressant medication (both required if suicidal ). Following this trial, some participants whose depression symptoms improved significantly during the first study chose to enroll in a year-long follow-up study.

article thumbnail

IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients

Cannabis Law Report

IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. This Phase 1 trial is currently testing IGC-AD1 for safety.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cannabinoids for Tinnitus?

Project CBD

For the next couple days, she got extra sleep to aid recovery, and for good measure took an extra dose or two of CBD. Whatever the precise nature of the phantom sound, it often comes with a constellation of symptoms related to the disruption such a condition can bring: sleep problems, difficulty concentrating, low mood, etc.

article thumbnail

What is CBN (Cannabinol)? How does the natural byproduct of THC work?

The Cannigma

Of course, this plant is now known to be marijuana (or Type I cannabis), which is still commonly used for sleep and analgesia today. In a 2019 animal study, CBN isolate was reported to relieve musculoskeletal pain. What can the current clinical trials tell us?

THC
article thumbnail

Getting to Know Cannabigerol with Bonni Goldstein, MD

Project CBD

And it does appear to address some of the main issues that people turn to cannabis for — inflammation, pain, anxiety, sleep problems, depression, and cancer. It was highly rated for anxiety, pain, depression, and sleep problems. But we may be on the cusp of having those trials, which would be very exciting.

article thumbnail

Cannabis 3.0 Accelerates Access to Consumer and Medical Research

Cannabis Law Report

Moreover over half of current cannabis users (52%) used apps on their mobile phone/tablet yesterday, with 66% reporting mobile app usage in the past week, and 74% reporting use in the past month, according to Vividata’s Spring Cannabis Consumer Study 2019. Virtual Clinical Trials transcend geographic, mobility and economic barriers.

article thumbnail

Medical Marijuana For Anxiety And Mood Disorder Treatment

LifeCannMD

Sleep Improvement: Many PTSD sufferers experience insomnia and nightmares. Cannabis, particularly strains high in THC, can improve sleep quality and reduce the frequency of nightmares. Various clinical trials are investigating the effectiveness of cannabis and its components in treating PTSD symptoms.